Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1996 Apr;117(7):1471–1474. doi: 10.1111/j.1476-5381.1996.tb15308.x

Investigation of endogenous nitric oxide vascular function in the carotid artery of cholesterol-fed rabbits.

D W Laight 1, J Matz 1, B Caesar 1, M J Carrier 1, E E Anggård 1
PMCID: PMC1909469  PMID: 8730741

Abstract

1. The function of endogenous nitric oxide (NO) at the level of vascular smooth muscle, was assessed in a popular experimental model of accelerated atherosclerosis, the cholesterol-fed rabbit. 2. Endothelium-dependent vasorelaxation in response to acetylcholine (ACh, 1 microM) was significantly impaired in the carotid artery from rabbits maintained on a 1% (W/W) cholesterol diet for 8-10 weeks. Furthermore, the ability of an inhibitor of nitric oxide synthase (NOS), NG-nitro-L-arginine methyl ester (L-NAME, 1-300 microM), to enhance the contractile reactivity to a submaximal concentration of noradrenaline (NA, 3 microM), was significantly attenuated in hypercholesterolaemia. 3. A significant linear correlation between the maximal contractile effect of L-NAME (300 microM) and maximal vasorelaxation to ACh (1 microM) was determined in the carotid artery from control rabbits. In contrast, no such linear correlation was found in the carotid artery from hypercholesterolaemic rabbits. 4. We conclude that there are lesions both in agonist-stimulated, endogenous NO-dependent vasorelaxation and in the regulation of vasoconstrictor reactivity by endogenous NO in the hypercholesterolaemic rabbit carotid artery. Furthermore, the normal linear relationship between the contractile effect of L-NAME and vasorelaxation to ACh is lost after cholesterol-feeding.

Full text

PDF
1471

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arribas S., Marín J., Ponte A., Balfagón G., Salaices M. Norepinephrine-induced relaxations in rat aorta mediated by endothelial beta adrenoceptors. Impairment by ageing and hypertension. J Pharmacol Exp Ther. 1994 Aug;270(2):520–527. [PubMed] [Google Scholar]
  2. Blanchard D. G., Ross J., Jr Hypertrophic cardiomyopathy: prognosis with medical or surgical therapy. Clin Cardiol. 1991 Jan;14(1):11–19. doi: 10.1002/clc.4960140105. [DOI] [PubMed] [Google Scholar]
  3. Du Z. Y., Dusting G. J., Woodman O. L. Inhibition of nitric oxide synthase specifically enhances adrenergic vasoconstriction in rabbits. Clin Exp Pharmacol Physiol. 1992 Jul;19(7):523–530. doi: 10.1111/j.1440-1681.1992.tb00499.x. [DOI] [PubMed] [Google Scholar]
  4. Flavahan N. A. Atherosclerosis or lipoprotein-induced endothelial dysfunction. Potential mechanisms underlying reduction in EDRF/nitric oxide activity. Circulation. 1992 May;85(5):1927–1938. doi: 10.1161/01.cir.85.5.1927. [DOI] [PubMed] [Google Scholar]
  5. Furchgott R. F., Zawadzki J. V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 1980 Nov 27;288(5789):373–376. doi: 10.1038/288373a0. [DOI] [PubMed] [Google Scholar]
  6. Gray D. W., Marshall I. Novel signal transduction pathway mediating endothelium-dependent beta-adrenoceptor vasorelaxation in rat thoracic aorta. Br J Pharmacol. 1992 Nov;107(3):684–690. doi: 10.1111/j.1476-5381.1992.tb14507.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Guc M. O., Furman B. L., Paratt J. R. Modification of alpha-adrenoceptor-mediated pressor responses by NG-nitro-L-arginine methyl ester and vasopressin in endotoxin-treated pithed rats. Eur J Pharmacol. 1992 Nov 24;224(1):63–69. doi: 10.1016/0014-2999(92)94819-h. [DOI] [PubMed] [Google Scholar]
  8. Harrison D. G. Endothelial dysfunction in atherosclerosis. Basic Res Cardiol. 1994;89 (Suppl 1):87–102. doi: 10.1007/978-3-642-85660-0_8. [DOI] [PubMed] [Google Scholar]
  9. Kaneko K., Sunano S. Involvement of alpha-adrenoceptors in the endothelium-dependent depression of noradrenaline-induced contraction in rat aorta. Eur J Pharmacol. 1993 Aug 24;240(2-3):195–200. doi: 10.1016/0014-2999(93)90898-r. [DOI] [PubMed] [Google Scholar]
  10. Knowles R. G., Moncada S. Nitric oxide synthases in mammals. Biochem J. 1994 Mar 1;298(Pt 2):249–258. doi: 10.1042/bj2980249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Lefer A. M., Lefer D. J. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Annu Rev Pharmacol Toxicol. 1993;33:71–90. doi: 10.1146/annurev.pa.33.040193.000443. [DOI] [PubMed] [Google Scholar]
  12. Lefer A. M., Ma X. L. Decreased basal nitric oxide release in hypercholesterolemia increases neutrophil adherence to rabbit coronary artery endothelium. Arterioscler Thromb. 1993 Jun;13(6):771–776. doi: 10.1161/01.atv.13.6.771. [DOI] [PubMed] [Google Scholar]
  13. MacLean M. R., McCulloch K. M., McGrath J. C. Influences of the endothelium and hypoxia on alpha 1- and alpha 2-adrenoceptor-mediated responses in the rabbit isolated pulmonary artery. Br J Pharmacol. 1993 Jan;108(1):155–161. doi: 10.1111/j.1476-5381.1993.tb13456.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Matz J., Andersson T. L., Ferns G. A., Anggård E. E. Dietary vitamin E increases the resistance to lipoprotein oxidation and attenuates endothelial dysfunction in the cholesterol-fed rabbit. Atherosclerosis. 1994 Oct;110(2):241–249. doi: 10.1016/s0021-9150(94)90208-9. [DOI] [PubMed] [Google Scholar]
  15. Minor R. L., Jr, Myers P. R., Guerra R., Jr, Bates J. N., Harrison D. G. Diet-induced atherosclerosis increases the release of nitrogen oxides from rabbit aorta. J Clin Invest. 1990 Dec;86(6):2109–2116. doi: 10.1172/JCI114949. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Mitchell J. A., Kohlhaas K. L., Sorrentino R., Warner T. D., Murad F., Vane J. R. Induction by endotoxin of nitric oxide synthase in the rat mesentery: lack of effect on action of vasoconstrictors. Br J Pharmacol. 1993 May;109(1):265–270. doi: 10.1111/j.1476-5381.1993.tb13563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Moncada S., Palmer R. M., Higgs E. A. Nitric oxide: physiology, pathophysiology, and pharmacology. Pharmacol Rev. 1991 Jun;43(2):109–142. [PubMed] [Google Scholar]
  18. Mügge A., Elwell J. H., Peterson T. E., Harrison D. G. Release of intact endothelium-derived relaxing factor depends on endothelial superoxide dismutase activity. Am J Physiol. 1991 Feb;260(2 Pt 1):C219–C225. doi: 10.1152/ajpcell.1991.260.2.C219. [DOI] [PubMed] [Google Scholar]
  19. Najibi S., Cowan C. L., Palacino J. J., Cohen R. A. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol. 1994 May;266(5 Pt 2):H2061–H2067. doi: 10.1152/ajpheart.1994.266.5.H2061. [DOI] [PubMed] [Google Scholar]
  20. Osborne J. A., Siegman M. J., Sedar A. W., Mooers S. U., Lefer A. M. Lack of endothelium-dependent relaxation in coronary resistance arteries of cholesterol-fed rabbits. Am J Physiol. 1989 Mar;256(3 Pt 1):C591–C597. doi: 10.1152/ajpcell.1989.256.3.C591. [DOI] [PubMed] [Google Scholar]
  21. Palmer R. M., Ashton D. S., Moncada S. Vascular endothelial cells synthesize nitric oxide from L-arginine. Nature. 1988 Jun 16;333(6174):664–666. doi: 10.1038/333664a0. [DOI] [PubMed] [Google Scholar]
  22. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  23. Pomerantz K. B., Hajjar D. P., Levi R., Gross S. S. Cholesterol enrichment of arterial smooth muscle cells upregulates cytokine-induced nitric oxide synthesis. Biochem Biophys Res Commun. 1993 Feb 26;191(1):103–109. doi: 10.1006/bbrc.1993.1190. [DOI] [PubMed] [Google Scholar]
  24. Rajanayagam M. A., Rand M. J. Differential activation of adrenoceptor subtypes by noradrenaline applied from the intimal or adventitial surfaces of rat isolated tail artery. Clin Exp Pharmacol Physiol. 1993 Dec;20(12):793–799. doi: 10.1111/j.1440-1681.1993.tb03017.x. [DOI] [PubMed] [Google Scholar]
  25. Rees D. D., Palmer R. M., Schulz R., Hodson H. F., Moncada S. Characterization of three inhibitors of endothelial nitric oxide synthase in vitro and in vivo. Br J Pharmacol. 1990 Nov;101(3):746–752. doi: 10.1111/j.1476-5381.1990.tb14151.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature. 1993 Apr 29;362(6423):801–809. doi: 10.1038/362801a0. [DOI] [PubMed] [Google Scholar]
  27. Stewart-Lee A. L., Forster L. A., Nourooz-Zadeh J., Ferns G. A., Anggård E. E. Vitamin E protects against impairment of endothelium-mediated relaxations in cholesterol-fed rabbits. Arterioscler Thromb. 1994 Mar;14(3):494–499. doi: 10.1161/01.atv.14.3.494. [DOI] [PubMed] [Google Scholar]
  28. Szabó C., Mitchell J. A., Thiemermann C., Vane J. R. Nitric oxide-mediated hyporeactivity to noradrenaline precedes the induction of nitric oxide synthase in endotoxin shock. Br J Pharmacol. 1993 Mar;108(3):786–792. doi: 10.1111/j.1476-5381.1993.tb12879.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Tsutsui M., Shimokawa H., Tanaka S., Kuwaoka I., Hase K., Nogami N., Nakanishi K., Okamatsu S. Endothelial Gi protein in human coronary arteries. Eur Heart J. 1994 Sep;15(9):1261–1266. doi: 10.1093/oxfordjournals.eurheartj.a060662. [DOI] [PubMed] [Google Scholar]
  30. Vallance P., Calver A., Collier J. The vascular endothelium in diabetes and hypertension. J Hypertens Suppl. 1992 Apr;10(1):S25–S29. doi: 10.1097/00004872-199204001-00006. [DOI] [PubMed] [Google Scholar]
  31. Verbeuren T. J., Bonhomme E., Laubie M., Simonet S. Evidence for induction of nonendothelial NO synthase in aortas of cholesterol-fed rabbits. J Cardiovasc Pharmacol. 1993 May;21(5):841–845. doi: 10.1097/00005344-199305000-00023. [DOI] [PubMed] [Google Scholar]
  32. Woditsch I., Schrör K. Reduced endothelium-dependent relaxation at enhanced NO release in hearts of hypercholesterolaemic rabbits. Br J Pharmacol. 1994 Apr;111(4):1035–1040. doi: 10.1111/j.1476-5381.1994.tb14848.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Zanzinger J., Czachurski J., Seller H. Inhibition of sympathetic vasoconstriction is a major principle of vasodilation by nitric oxide in vivo. Circ Res. 1994 Dec;75(6):1073–1077. doi: 10.1161/01.res.75.6.1073. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES